Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by aussyspitzon Jul 12, 2020 11:30am
152 Views
Post# 31257359

Sometimes the glass really is half empty

Sometimes the glass really is half emptyConfirmed, BLA will be submitted this quarter ( instead of H1, reason is because they can use covid delays as another excuse for incompetent management that never changes)

Ryplazim partnership (cash upfront) from who exactly?  It would take a company that had an off the charts incompetence level equal to or worse than Liminal's to want to lie in bed with this pos.

Very worst scenario imo, they simply sell a stake of LMNL, owners control 85% of all shares, so no dilution - The fact that they own 85% of the shares has absolutely zero bearing on whether or not they will dilute in fact if anything it actually makes it more likely that they will as they can issue approximately 8.73M more shares/warrants while still maintaing 51% control and essentially reduce retail ownership's total stake to near zero 

In your opinion the surge in nasdaq and sp is a leak. In my opinion it was low info American investors merely pumping money into anything even mentioning COVID similar to the early dotcom days

...lets be patient, wont be long.  IMO its 50/50 that they may actually finally come through with the submission of the BLA in mid to late September if they do the share price will likely spike some however look for insiders to dump shares right before they announce dilution likely within a month or two if not weeks following the BLA submission .
<< Previous
Bullboard Posts
Next >>